semaglutide legal Ozempic Lawsuit: Side Effects, Risks & Options semaglutide side effect lawyer in
Description
doi: 10.3389/FENDO.2022.851035
Retrieved 2018-02-28
Notably, no increase in the hypoglycemic events is reported with SGLT2 inhibitors or sotagliflozin, compared to a placebo group in T1D subjects
If the priority is glycaemic control or cardiometabolic health, then moderate dosages like 4 mg or 8 mg might already offer the majority of the benefit without excess side effect burden
